DB
SYNH

Dmitry Balyasny’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Dmitry Balyasny’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,620,879
Closed -$68.3M – 2869
2023
Q2 		$68.3M Buy
1,620,879
+863,267
+114% +$34.9M 0.15% 174
2023
Q1 		$27M Buy
757,612
+756,940
+112,640% +$27.5M 0.07% 422
2022
Q4 		$24.6K Sell
672
-256,643
-100% -$10.1M ﹤0.01% 2455
2022
Q3 		$12.1M Buy
257,315
+234,716
+1,039% +$15.2M 0.04% 598
2022
Q2 		$1.62M Sell
22,599
-26,378
-54% -$1.93M 0.01% 1522
2022
Q1 		$3.96M Sell
48,977
-15,603
-24% -$1.32M 0.01% 1050
2021
Q4 		$6.63M Sell
64,580
-36,498
-36% -$3.5M 0.02% 756
2021
Q3 		$8.84M Sell
101,078
-207,915
-67% -$18.8M 0.04% 625
2021
Q2 		$27.7M Buy
308,993
+112,720
+57% +$9.52M 0.13% 209
2021
Q1 		$14.9M Buy
+196,273
New +$14.8M 0.07% 369
2020
Q3 		– Sell
-92,075
Closed -$5.48M – 1676
2020
Q2 		$5.36M Sell
92,075
-35,711
-28% -$1.92M 0.05% 502
2020
Q1 		$5.04M Sell
127,786
-38,314
-23% -$2.24M 0.06% 401
2019
Q4 		$9.88M Buy
+166,100
New +$8.93M 0.06% 434
2019
Q1 		– Sell
-21,954
Closed -$864K – 1729
2018
Q4 		$864K Sell
21,954
-71,532
-77% -$3.32M 0.01% 942
2018
Q3 		$4.82M Buy
93,486
+30,057
+47% +$1.47M 0.02% 712
2018
Q2 		$2.98M Sell
63,429
-82,819
-57% -$3.43M 0.01% 811
2018
Q1 		$5.19M Sell
146,248
-1,530,634
-91% -$60M 0.02% 698
2017
Q4 		$73.1M Buy
+1,676,882
New +$78.3M 0.23% 100
2017
Q2 		– Sell
-898,161
Closed -$41.2M – 1832
2017
Q1 		$41.2M Buy
898,161
+843,807
+1,552% +$42M 0.19% 131
2016
Q4 		$2.86M Buy
+54,354
New +$2.63M 0.02% 823
2016
Q3 		– Sell
-12,772
Closed -$487K – 1334
2016
Q2 		$487K Buy
12,772
+3,957
+45% +$174K ﹤0.01% 829
2016
Q1 		$363K Sell
8,815
-15,360
-64% -$633K ﹤0.01% 960
2015
Q4 		$1.17M Sell
24,175
-140,399
-85% -$6.25M 0.01% 696
2015
Q3 		$6.58M Buy
+164,574
New +$7.19M 0.05% 453

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $88.9B AUM 38.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $46.7B AUM 50.59% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Dmitry Balyasny's SYNH Position: Q3 2023 in Review

Dmitry Balyasny sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,620,879 shares — an estimated $68.3M sold.

Dmitry Balyasny first reported a position in SYNH in Q3 2015 and held it in 24 quarters. The position peaked at $73.1M in Q4 2017. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Dmitry Balyasny reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Dmitry Balyasny sold 1,620,879 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $68.3M.
  • Dmitry Balyasny first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 24 quarters.
  • Dmitry Balyasny's Syneos Health, Inc. Class A Common Stock position peaked at $73.1M in Q4 2017.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.